Veronica H-Stevenson

Veronica has a BSc in Reproductive Anatomy and Structural Biology and a Masters in Science Communication. She pulls academic research into alignment with market needs and translates technical outcomes into business strategy. Veronica sits on the Return on Science Momentum Investment Committee and is a Judge for KiwiNet's Science Commercialisation Awards. [LinkedIn]

Founder / Director

Ryan Graves

Ryan has a PhD in Neuroscience, with foundations in molecular biology. He has worked in a variety of lab environments, including academic science and the pharmaceutical industry in NZ and the UK. He is also co-founder of a biotech startup where he oversaw pre-clinical studies, IP development, clinical trial development and translated technical data for capital raising and regulatory approvals. He has also worked in government as a science investment manager, and in the University sector as a commercialisation manager. [LinkedIn]

CTO and Interim CEO

Christie Dunwoodie

Christie has over 15 years of corporate, commercial, financial services and SME/start up experience. She holds a Bachelor of Commerce, has a passion for innovative businesses and “getting the numbers right”. She has a broad experience base that includes management accounting & reporting, business process improvement, system implementation and has delivered in senior positions in NZ, UK and Switzerland. [LinkedIn]

CFO

Lauren Cross

Lauren has over 15  years experience in project management, governance and business analysis in companies ranging from global financial institutions to tech startups. Lauren has a Bachelor of Arts in Psychology and a Diploma in Project Management and is passionate about the successful delivery of project outcomes and business change. [LinkedIn]

Operations Manager

Julia Chambers

Julia brings over 20 years of executive and director-level experience in the technology sector, including extensive biopharmaceutical and medical technology industry coverage. With her background in business development, strategy, and capital raising in bioscience, she helps high-growth technology companies and innovative businesses thrive on the global stage.  [LinkedIn]

Chair of the Board

Andrew West

With his PhD in Ecology, plus extensive training and experience in business administration and governance, Andrew is a scientist turned entrepreneur. Since 2015, he has co-founded and led five science-based and high-tech companies. He has special expertise in food and environmental industries. Having been a public servant, he also has special insight into working with elected officials and governmental departments to promote science and effect change.

Director

Richard Furneaux

Richard founded, led, and grew the IRL (now Callaghan Innovation) carbohydrate chemistry research team over 20 years. He has been the Director of The Ferrier Institute for the last four.  His expertise in science commercialisation is internationally recognised, and in 2017 he won the KiwiNet Supreme Award for science commercialisation. [LinkedIn]

Director

Henry Hebel

Henry has over 25 years of biopharmaceutical development experience. Most recently, he served as COO at Aldevron where he was responsible for strategy and execution to rapidly expand the company to 750+ employees and manufacturing capacity to nearly 250,000 sq.ft. (23,000 sq.m.) within three years, resulting in a pending US$9.6 Billion acquisition by Danaher Corporation. Henry holds a BS degree in Zoology and an MBA from Texas A&M University. He has been awarded multiple patents and dozens of his writings have been published in industry journals. [LinkedIn]

Director

Leadership